Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.

Source: Fountou-lakis, S., et al. 2015 - Pubmed ID: 26188234

Setting: Greece, Hospital

Study design:

RCT

Follow up: 12 months

Patient group:

Sample size:

Total: 115 (105)

IG: 76 (70)

CG: 39 (35)

Inclusion criteria:

Diabetes 1 +2

Type of technology:

Home monitoring equipment

– Glucometer

– USB connected modem (datatransfer)

 

Telecommunication

– SMS

– email

Intervention:

Intervention:

– Pt. transmit data every day

– An endocrinologist reviewed the data and contacted participants via mobile phone SMS or e-mails when necessary.

– Alerts were set for high or low glucose levels

– When alerts were activated, the endocrinologist received a text-message thus allowing prompt communication and proper therapeutic adjustments.

Duration: 6 months

Add on:

 

Control group:

bimonthly care as provided by outpatient department endocrinologists

Clinical effect/ Patient safety:

Clinical effect:

– HbA1c ↓

– BMI →

– freq. glucose measurement →

– Hypoglycemia↓

Patient safety:

NA

Patient experiences/ Staff experiences:

Patient experiences:

NA

Staff experiences:

Mean

time dedicated per IG patient per month: 10 min

Costs and organization:

Investment:

Home monitoring equipment

– Blood glucose

Running:

– Staff for monitoring clinical data and for contacting patients

Organization:

NA

Health care utilization:

NA

Scroll to Top

Information

“↑”: Statistically significant increase

“↓”: Statistically significant decrease

“→”: Statistically insignificant (no difference)